Page last updated: 2024-10-21

pleconaril and Protein-Losing Enteropathies

pleconaril has been researched along with Protein-Losing Enteropathies in 1 studies

WIN 63843: structure given in first source

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van de Ven, AA1
Douma, JW1
Rademaker, C1
van Loon, AM1
Wensing, AM1
Boelens, JJ1
Sanders, EA1
van Montfrans, JM1

Other Studies

1 other study available for pleconaril and Protein-Losing Enteropathies

ArticleYear
Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia.
    Antiviral therapy, 2011, Volume: 16, Issue:4

    Topics: Adolescent; Agammaglobulinemia; Antiviral Agents; Caliciviridae Infections; Chronic Disease; Drug Re

2011